Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies.
about
Methylation of kruppel-like factor 2 (KLF2) associates with its expression and non-small cell lung cancer progression.CDH22 hypermethylation is an independent prognostic biomarker in breast cancer.CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.DNA methylation profiles in cancer diagnosis and therapeutics.GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic ImplicationsPrognostic significance of GSTP1 in patients with triple negative breast cancer.
P2860
Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Aberrant GSTP1 promoter methyl ...... is of 19 case-control studies.
@ast
Aberrant GSTP1 promoter methyl ...... is of 19 case-control studies.
@en
type
label
Aberrant GSTP1 promoter methyl ...... is of 19 case-control studies.
@ast
Aberrant GSTP1 promoter methyl ...... is of 19 case-control studies.
@en
prefLabel
Aberrant GSTP1 promoter methyl ...... is of 19 case-control studies.
@ast
Aberrant GSTP1 promoter methyl ...... is of 19 case-control studies.
@en
P2093
P2860
P1433
P1476
Aberrant GSTP1 promoter methyl ...... sis of 19 case-control studies
@en
P2093
Cheng Fang
Fu-Bing Wang
Xinghua Long
Xue-Mei Wei
P2860
P2888
P356
10.1186/S12885-015-1926-1
P407
P577
2015-11-19T00:00:00Z
P5875
P6179
1045702377